跳至主要内容
临床试验/NL-OMON31476
NL-OMON31476已完成不适用

Duloxetine plus collaborative care treatment versus Duloxetine alone in the treatment of concomitant pain and depressive disorder. A randomized clinical trial in primary care. - CC:PAINDIP (collaborative care: pain depression in primary healthcare)

Trimbos instituut0 个研究点目标入组 116 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients will be selected that have presented themselves with pain at their primary care physician. They will be approached for the study and asked informed consent. If they consent, they will be screened with the PHQ for depressive disorder and the BPI (brief pain inventory). In case of a cut-off score of >10 on the PHQ and a score of >= 3 on the 'average pain' item of the BPI, they will be included in the study.

排除标准

  • Exclusion criteria will be: cancer; recent post traumatic pain; alcohol or drug abuse; suicidal ideation; psychotic symptoms; dementia; somatization disorder; or already being under psychiatric treatment. Also, all contraindications known by the PCP for Duloxetine will be exclusion criteria as well.

研究者

相似试验